Short-term stake in Sino Biopharmaceutical Limited (OTCMKTS: SBMFF) decreases by 37.3%

Sino Biopharmaceutical Limited (OTCMKTS: SBMFFGet a rating) benefited from a sharp drop in short-term interest rates during the month of May. As of May 15, there was short interest totaling 3,377,000 shares, down 37.3% from the April 30 total of 5,384,000 shares. Based on an average trading volume of 1,100 shares, the day-to-cover ratio is currently 3,070.0 days.

Shares of SBMFF action opened at $0.50 on Friday. The company’s 50-day moving average price is $0.54 and its 200-day moving average price is $0.64. Sino Biopharmaceutical has a 12-month low of $0.46 and a 12-month high of $1.12.

Sino Biopharmaceutical Company Profile (Get a rating)

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China. It operates through three segments: Modernized Chinese Medicines and Chemical Medicines, Investment and Others. The Company’s products include oncology drugs including Qingkeshu tablets, Anxian capsules, Yinishu tablets, Genike capsules, Anyue capsules and Leweixin injections; cardiocerebral vascular drugs, including Kaina and Anrixin tablets; hepatitis medications, such as Tianqingganmei injections and Tianqingganping enteric capsules; orthopedic medicines consisting of Gaisanchun capsules, Yigu injections and Taiyan tablets; medicines for the respiratory system; parenteral nutrient drugs including Xinhaineng and Fenghaina injections; and other medications, including Tuotuo tablets, Debaian poultices, and Qingliming injections.

Further reading

Get news and reviews for Sino Biopharmaceutical Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Sino Biopharmaceutical and related companies with’s FREE daily email newsletter.

Comments are closed.